Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Clinical Trials in Spain / NCT07529743
Starting soon Not applicable

Multicomponent Exercise and Virtual Reality for Older Adults

NCT07529743 · tracked via the Priya Life Science Spain tracker
Sponsor
European University Miguel de Cervantes
Phase
Not applicable
Started
2026-04-07
Last updated
2026-04-14

Condition(s) studied

FrailtyAgingFunctional Impairment

Investigational drug(s) / intervention(s)

Multicomponent Exercise plus Non-Immersive Virtual RealityNon-Immersive Virtual Reality

Multicomponent Exercise plus Non-Immersive Virtual Reality: Participants will undergo an 8-week multicomponent exercise program combined with non-immersive virtual reality (VR). Sessions will be conducted twice weekly (60 minutes each) and will include strength, balance, coordination, and functional mobility training, along with VR-based motor and cognitive stimulation using a non-immersive system. The intervention will be delivered in a supervised group setting.

Non-Immersive Virtual Reality: Participants will receive non-immersive virtual reality training for 8 weeks, with two supervised sessions per week (60 minutes each), focused on motor and cognitive stimulation.

Study summary

Population aging is associated with an increased risk of frailty, falls, and loss of autonomy. This pilot study aims to evaluate the effects of a program that combines multicomponent exercise and non-immersive virtual reality (MCE+VR-NI), compared with virtual reality alone (VR-NI) and usual treatment. The primary objective is to determine the program's impact on physical function, balance, cognition, and occupational participation in community-dwelling adults aged over 65 years.

Eligibility

Sex
ALL
Min age
65 Years
Max age
—
Healthy volunteers
Accepted
Inclusion Criteria: * Participants must be aged 65 years or older. * A score of ≥23 points on the Montreal Cognitive Assessment (MoCA) score * Functional independence or minimal dependence in activities of daily living (A score of \>90 on the Barthel Index). * Participants must be able to understand instructions and provide written informed consent. Exclusion Criteria: * Conditions that prevent walking or safe participation in a group intervention.

Primary outcome measure(s)

  • Change in physical function (SPPB score) — Baseline and 8 weeks
    Physical function will be assessed using the Short Physical Performance Battery (SPPB), which includes balance, gait speed, and chair stand tests, with a total score ranging from 0 to 12. Higher scores indicate better physical function.

Trial sites (1)

FacilityCityRegionStatus
INNOVEAS Innovation Center, Spanish Red Cross (Valladolid), Spain Valladolid Valladolid

More European University Miguel de Cervantes trials in Spain

Acute Effects of High-intensity Interval Aerobic and Functional Training at Different Intensities Recruiting
Impact of Prehabilitation and Comprehensive Follow-up in Women With Breast Cancer Recruiting
Effects of a Isokinetic Exercise in Women With Fibromyalgia Recruiting
Life Monitoring for Rural Older Adults Recruiting

Other trials for the same condition

Benefits of Strength Training in Informal Caregivers of Patients With Alzheimer's Disease Starting soon
The SHAPE Project (Hospital System for Physical Activity and Active Participation) After Hospitalized Decompensation of Respiratory Chronic Diseases Starting soon
Remote vs In-Person Prehabilitation for Kidney Transplant Candidates Starting soon
Impact of Funcional Exercise and Supplementation in Perimenopausal Women's Health Recruiting
Population Cohort Set-up for the Epidemiological Assessment of Balance Disorders in Elderly People Active, not recruiting
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07529743 on ClinicalTrials.gov ↗ ← All trials in Spain